BridgeBio Oncology Therapeutics's top three insider shareholders as of August 04, 2026 are Bihua Chen (Director, 17.88Mn shares), Pharma Llc Bridgebio (TenPercentOwner, 14.59Mn shares), Bihua Chen (Ceo And Chairperson, 903.60K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Bihua Chen | - | 0 | 17,878,594 | 13 Aug, 2025 |
| Holdings Ii Llc Helix | - | 0 | 509,000 | 13 Feb, 2024 |
| Uneek Mehra | Chief Financial Officer | 23,330 | 0 | 12 Mar, 2026 |
| Yong Ben | Chief Med Dev Officer | 46,670 | 0 | 12 Mar, 2026 |
| Albert A Iii Holman | - | 30,000 | 0 | 11 Aug, 2025 |
| Pedro Beltran | Chief Scientific Officer | 46,670 | 0 | 12 Mar, 2026 |
| Pharma Llc Bridgebio | - | 14,589,846 | 0 | 16 Oct, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 24 Mar, 2026 | Peter F Lebowitz | Stock Option (Right to Buy) | A | 63,350 | $0.00 | 63,350 | D | A |
| 24 Mar, 2026 | Peter F Lebowitz | Stock Option (Right to Buy) | A | 63,350 | $0.00 | 63,350 | D | A |
| 24 Mar, 2026 | Peter F Lebowitz | Stock Option (Right to Buy) | A | 63,350 | $0.00 | 63,350 | D | A |
| 10 Mar, 2026 | Yong Ben | Common Stock | A | 46,670 | $0.00 | 46,670 | D | A |
| 10 Mar, 2026 | Pedro Beltran | Common Stock | A | 46,670 | $0.00 | 46,670 | D | A |
| 10 Mar, 2026 | Uneek Mehra | Common Stock | A | 23,330 | $0.00 | 23,330 | D | A |
| 10 Mar, 2026 | Uneek Mehra | Stock Option (Right to Buy) | A | 105,000 | $0.00 | 105,000 | D | A |
| 10 Mar, 2026 | Pedro Beltran | Stock Option (Right to Buy) | A | 210,000 | $0.00 | 210,000 | D | A |
| 10 Mar, 2026 | Yong Ben | Stock Option (Right to Buy) | A | 210,000 | $0.00 | 210,000 | D | A |
| 01 Jan, 2026 | Eli M. Wallace | Stock Option (Right to Buy) | A | 1,114,400 | $0.00 | 1,114,400 | D | A |
| 01 Jan, 2026 | Eli M. Wallace | Stock Option (Right to Buy) | A | 1,114,400 | $0.00 | 1,114,400 | D | A |
| 01 Jan, 2026 | Eli M. Wallace | Stock Option (Right to Buy) | A | 1,114,400 | $0.00 | 1,114,400 | D | A |
| 10 Dec, 2025 | Eli M. Wallace | Stock Option (Right to Buy) | D | 1,114,400 | - | 500,000 | D | D |
| 10 Dec, 2025 | Eli M. Wallace | Stock Option (Right to Buy) | D | 1,114,400 | - | 500,000 | D | D |
| 10 Dec, 2025 | Eli M. Wallace | Stock Option (Right to Buy) | D | 1,114,400 | - | 500,000 | D | D |
| 10 Oct, 2025 | Pharma Llc Bridgebio | Common Stock | A | 784,720 | - | 14,589,846 | D | J |
| 10 Oct, 2025 | Pharma Llc Bridgebio | Common Stock | A | 784,720 | - | 14,589,846 | D | J |
| 10 Oct, 2025 | Pharma Llc Bridgebio | Common Stock | A | 784,720 | - | 14,589,846 | D | J |
| 02 Oct, 2025 | Eli M. Wallace | Stock Option (Right to Buy) | A | 1,614,400 | $0.00 | 1,614,400 | D | A |
| 02 Oct, 2025 | Eli M. Wallace | Stock Option (Right to Buy) | A | 1,614,400 | $0.00 | 1,614,400 | D | A |